Sabine Hadida
Sabine Hadida | |
|---|---|
| Education | University of Barcelona |
| Occupation | Senior Vice President |
| Employer | Vertex Pharmaceuticals |
| Known for | Research in cystic fibrosis |
Sabine Hadida is a pharmacologist and senior vice president at Vertex Pharmaceuticals. She works at Vertex's cystic fibrosis research center in San Diego. She was awarded the Breakthrough Prize in Life Sciences in 2024.
Education
[edit]Hadida has a bachelor's degree, master's degree, and Ph.D. in pharmacy from the University of Barcelona, Spain.[1] She worked as a postdoctoral fellow at the University of Pittsburgh studying fluorous chemistry.[1]
Career
[edit]At Vertex Pharmaceuticals, Hadida led the chemistry team to work on drug treatments for cystic fibrosis and pain.[1]
Awards and honors
[edit]Hadida is the recipient of the 2022 Drug Hunter Award, the 2019 Distinguished Scientist Award by the American Chemistry Society, San Diego Chapter, and the 2013 American Chemistry Society Heroes of Chemistry award.[1][2]
In September 2023, she received the 2024 Breakthrough Prize in Life Sciences alongside Paul Negulescu and Frederick Van Goor, for developing treatment for cystic fibrosis.[3]
References
[edit]- ^ a b c d "The 21st Annual Wiley Prize in Biomedical Sciences". Events & Lectures. Retrieved 2023-09-27.
- ^ "Heroes of Chemistry - Archive". American Chemical Society. Retrieved 2023-09-27.
- ^ "Breakthrough Prize – Life Sciences Breakthrough Prize Laureates – Sabine Hadida". breakthroughprize.org. Retrieved 2023-09-27.
 | This article needs additional or more specific categories. (October 2023) |